维普期刊资源整合服务平台（V6.5）

163篇 您的检索式：作者名="Treon SP"

选中清除导出查看参考文献查看引证文献引用追踪共9页首页上一页第1页下一页末页 /9 跳转

	题名	作者	年代	出处	被引量
1	MYD88 L265P somatic mutation in Waldenstriim's macroglobulinemia显示文摘	Treon SP Xu L Yang G	2012	N Engl J Med2012，367，9：	1
2	Muhicenter clinical trial of bortezomib in relapsed/refractory Waldenstrom's macroglobulinemia:results of WMCTG Trial 03-248显示文摘	Treon SP Hunter ZR	2007	Clin Cancer Res2007，13，：	1
3	Primary therapy of Waldenstrom's macroglobulinemia with bortezomib,dexameth-asone and rituximab:results of WMCTG clinical trail 05-180显示文摘	Treon SP Iokamidis L	2008	J Clin Oncol2008，26，：	1
4	Long-term outcomes to fludarabine and rituximab in Waldenstrm macroglobulinemia显示文摘	Treon SP Branagan AR Ioakimidis L	2009	Blood2009，113，16：	1
5	Elevated soluble MUC1 levels and decreased anti-MUC1 antibody levels in patients with multiple myeloma显示文摘	Treon SP Maimonis P Bua D	2000	Blood2000，96，9：	1
6	Concepts in use of high-dose methotrexate therapy显示文摘	STEVEN P TREON SP CHABNER BA	1996	Clin Chem1996，42，8：	1
7	Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applications显示文摘	Gupta D Treon SP Shima Y	2001	Leukemia2001，15，12：	1
8	Multicenter clinical trial of bortezomib in relapsed/refractory Waldenstrom's macroglobulinemia: results of WMCTG Trial 03-248 显示文摘	Treon SP Hunter ZR Matous J	2007	Clin Cancer Res2007，13，11：	1
9	MYD88 L265P somatic mutation in Waldenstrom macroglobulinemia显示文摘	Treon SP Xu L Yang G	2012	N Eng J Med2012，367，9：	1
10	Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion : therapeutic applications 显示文摘	Gupta D Treon SP Shima Y	2001	Leukemia2001，15，：	1
11	TRAIL/Apo2L ligand selectively induces apoptosis and overcomes drug resistance in multiple myeloma: therapeutic applications 显示文摘	Mitsiades CS Treon SP Mitsiades N	2001	Blood2001，98，3：	1
12	Clinicopathological definition of Waldenstromg macroglobulinemia: consensus panel recommenda- tions from the Second International Workshop on Waldenstromg Mac- mglobulinemia 显示文摘	Owen RG Treon SP A1-Katib A	2003	Semin Onco12003，30，：	1
13	Clinicopathological definition of Waldenstrom macroglobulinemia:consensus panel recommendations from the Second International Workshop on Waldenstrom Macroglobulinemia 显示文摘	Owen RG Treon SP Al-Katib A	2003	Semin Oncol2003，30，2：	1
14	Tumor cell expression of CD59 is associated with resistance to CD20 serotherapy in patients with B-cell malignancies显示文摘	Treon SP Mitsiades C Mitsiades N	2001	J Immunother2001，24，3：	1
15	A new era for Waldenstriim macroglobulinemia: MYD88 L265P显示文摘	Treon SP Hunter ZR	2013	Blood2013，121，22：	1
16	Long time outcomes to fludarabine and rituximabin Macroglobulinemia 显示文摘	TREON SP BRANAGAN AR HUNTER ZR	2009	Blood2009，113，16：	1
17	Recombinant humanized anti -CD40 monoclonal antibody triggers antolognus antibody-dependent cell-mediated cytotoxicity against multiple myeloma ceils显示文摘	Hayashi T Treon SP Hideshima T	2003	British Journal of Haematology2003，121，4：	1
18	Clinicopathological definition ofWaldenstriim's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstriim's Macroglobulinemia显示文摘	Owen RG Treon SP Al-Katib A	2003	Semin Oncol2003，30，2：	1
19	Concepts in use of high-dose methotrexate therapy显示文摘	Chabner BA	1996	Clinical Chemistry1996，42，2：	1
20	MYD88 L265P somatic mutation in Waldenstrom's macroglobulinemia显示文摘	Treon SP Xu L Yang C	2012	N Engl J Med2012，367，9：	1

返回顶部每页显示：

共9页首页上一页第1页下一页末页 /9 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示